{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Search results for valproic root_modifications_structuralModifications_molecularFragment_refPname in root_modifications_structuralModifications_molecularFragment_refPname (approximate match)
Status:
Investigational
Source:
INN:grisnilimab setaritox [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
INN:anzurstobart [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
INN:devextinetug [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
INN:linavonkibart [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT03797391: Phase 1/Phase 2 Interventional Recruiting Neoplasms
(2018)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
INN:mibavademab [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT04322149: Phase 2 Interventional Completed Amyotrophic Lateral Sclerosis
(2020)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT03530683: Phase 1 Interventional Terminated Lymphoma
(2018)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
INN:volrustomig [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT03238781: Phase 2 Interventional Completed Chronic Migraine or Episodic Migraine
(2017)
Source URL:
Class:
PROTEIN
